Ivabradine Shows Promise as Tx for Hyperadrenergic POTS

Further study needed in other POTS subtypes In patients with hyperadrenergic postural orthostatic tachycardia syndrome (POTS), one month of treatment with ivabradine brought about significant improvements in several parameters, including heart rate, quality of life (QOL), and plasma norepinephrine (NE) levels, according to results from a recent study published in the Journal of the American

PDF) Cognitive Dysfunction in Postural Tachycardia Syndrome.

Randomized Trial of Ivabradine in Patients With Hyperadrenergic

Ivabradine effects on COVID-19-associated postural orthostatic

Randomized Trial of Ivabradine in Patients With Hyperadrenergic

Frontiers Chronic Treatment with Ivabradine Does Not Affect

PDF) 2015 Heart Rhythm Society Expert Consensus Statement on the

ivabradine study results · MUSINGS OF A DYSAUTONOMIAC

PDF) Age-dependent modulation of xenobiotic metabolism in primary

Postural orthostatic tachycardia syndrome (POTS): a common but

Randomized Trial of Ivabradine in Patients With Hyperadrenergic

PDF) Ivabradine in Postural Orthostatic Tachycardia Syndrome: A